Location: Kinsale, Ireland

Network: API

The Kinsale program is one of Eli Lilly’s flagship manufacturing sites producing active pharmaceutical ingredients and advanced biopharmaceuticals for the company’s global portfolio. Recently expanded through an $800 million investment, the site now features state-of-the-art continuous manufacturing, automation, and AI-driven systems. It plays a critical role in supplying medicines for diabetes, obesity, and other key therapeutic areas, reinforcing Ireland’s position as a cornerstone of Lilly’s global manufacturing network.